Titan Pharmaceuticals
TTNP
#10412
Rank
โ‚น0.55 B
Marketcap
โ‚น416.38
Share price
-3.76%
Change (1 day)
41.41%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น396.51. In 2023 the company made an earnings per share (EPS) of -โ‚น669.29 an increase over its 2022 EPS that were of -โ‚น1,372.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น669.29-51.22%
2022-โ‚น1,372-15.61%
2021-โ‚น1,626-81.37%
2020-โ‚น8,725-77.52%
2019-โ‚น38,820-56.32%
2018-โ‚น88,878-59.51%
2017-โ‚น2,19,528-371.81%
2016โ‚น80,765-144.35%
2015-โ‚น1,82,091300%
2014-โ‚น45,523-121.54%
2013โ‚น2,11,355-151.38%
2012-โ‚น4,11,330-11.54%
2011-โ‚น4,64,982188.89%
2010-โ‚น1,60,955-10%
2009-โ‚น1,78,839
2007-โ‚น7,33,241-2.38%
2006-โ‚น7,51,125-39.13%
2005-โ‚น12,33,990-16.87%
2004-โ‚น14,84,365-22.43%
2003-โ‚น19,13,5794.9%
2002-โ‚น18,24,16061.9%
2001-โ‚น11,26,687-13.7%
2000-โ‚น13,05,52665.01%
1999-โ‚น7,91,193-35.87%
1998-โ‚น12,33,780-1824.71%
1997โ‚น71,536-102.4%
1996-โ‚น29,86,614

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-โ‚น128.26-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น21.68-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น305.29-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น942.91-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น664.77-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
โ‚น2.71-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA